1 |
Colonetti K, Pinto E Vairo F, Siebert M, Nalin T, Poloni S, Fernando Wurdig Roesch L, Fischinger Moura de Souza C, Cabral Pinheiro F, Vanessa Doederlein Schwartz I. Cytokine profiling in patients with hepatic glycogen storage disease: Are there clues for unsolved aspects? Cytokine 2023;162:156088. [PMID: 36462220 DOI: 10.1016/j.cyto.2022.156088] [Reference Citation Analysis]
|
2 |
Jarmakiewicz-Czaja S, Zielińska M, Sokal A, Filip R. Genetic and Epigenetic Etiology of Inflammatory Bowel Disease: An Update. Genes (Basel) 2022;13. [PMID: 36553655 DOI: 10.3390/genes13122388] [Reference Citation Analysis]
|
3 |
Li C, Wu Y, Xie Y, Zhang Y, Jiang S, Wang J, Luo X, Chen Q. Oral manifestations serve as potential signs of ulcerative colitis: A review. Front Immunol 2022;13:1013900. [DOI: 10.3389/fimmu.2022.1013900] [Reference Citation Analysis]
|
4 |
Duroux D, Climente-González H, Azencott CA, Van Steen K. Interpretable network-guided epistasis detection. Gigascience 2022;11:giab093. [PMID: 35134928 DOI: 10.1093/gigascience/giab093] [Reference Citation Analysis]
|
5 |
Fay NC, Muthusamy BP, Nyugen LP, Desai RC, Taverner A, MacKay J, Seung M, Hunter T, Liu K, Chandalia A, Coyle MP, Kim HL, Postlethwaite S, Mangat K, Song L, Seto E, Alam A, Olson CV, Feng W, Saberi M, Mahmood TA, Mrsny RJ. A Novel Fusion of IL-10 Engineered to Traffic across Intestinal Epithelium to Treat Colitis. J Immunol 2020;205:3191-204. [PMID: 33148717 DOI: 10.4049/jimmunol.2000848] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
|
6 |
Duroux D, Climente-gonzález H, Azencott C, Steen KV. Interpretable network-guided epistasis detection.. [DOI: 10.1101/2020.09.24.310136] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
7 |
Kundu K, Darden L, Moult J. MecCog: A knowledge representation framework for genetic disease mechanism.. [DOI: 10.1101/2020.09.03.282012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
8 |
Usategui-martín R, Lendinez-tortajada V, Pérez-castrillón JL, Briongos-figuero L, Abadía-otero J, Martín-vallejo J, Lara-hernandez F, Chaves FJ, García-garcia AB, Martín-escudero JC. Polymorphisms in genes involved in inflammation, the NF-kB pathway and the renin-angiotensin-aldosterone system are associated with the risk of osteoporotic fracture. The Hortega Follow-up Study. Bone 2020;138:115477. [DOI: 10.1016/j.bone.2020.115477] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
9 |
Younis N, Zarif R, Mahfouz R. Inflammatory bowel disease: between genetics and microbiota. Mol Biol Rep 2020;47:3053-63. [PMID: 32086718 DOI: 10.1007/s11033-020-05318-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 10.0] [Reference Citation Analysis]
|
10 |
Nobre R, Santander-jiménez S, Sousa L, Ilic A. Accelerating 3-Way Epistasis Detection with CPU+GPU Processing. Job Scheduling Strategies for Parallel Processing 2020. [DOI: 10.1007/978-3-030-63171-0_6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
11 |
Zhu S, Wang B, Jia Q, Duan L. Candidate single nucleotide polymorphisms of irritable bowel syndrome: a systemic review and meta-analysis. BMC Gastroenterol 2019;19:165. [PMID: 31615448 DOI: 10.1186/s12876-019-1084-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
12 |
Salvador-Martín S, López-Cauce B, Nuñez O, Laserna-Mendieta EJ, García MI, Lobato E, Abarca-Zabalía J, Sanjurjo-Saez M, Lucendo AJ, Marín-Jiménez I, Menchén LA, López-Fernández LA. Genetic predictors of long-term response and trough levels of infliximab in crohn's disease. Pharmacol Res 2019;149:104478. [PMID: 31605784 DOI: 10.1016/j.phrs.2019.104478] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
|
13 |
Berkowitz L, Pardo-Roa C, Ramírez G, Vallejos OP, Sebastián VP, Riedel CA, Álvarez-Lobos M, Bueno SM. The absence of interleukin 10 affects the morphology, differentiation, granule content and the production of cryptidin-4 in Paneth cells in mice. PLoS One 2019;14:e0221618. [PMID: 31509557 DOI: 10.1371/journal.pone.0221618] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
14 |
Khoshnevisan R, Vakili F, Klein C, Kotlarz D, Nasirian M, Sherkat R, Rezaei A. An analysis and survey of interleukin-10 receptor mutation in inflammatory bowel disease (IBD) in the first Iranian IBD cohort. Journal of Laboratory Medicine 2019;43:185-9. [DOI: 10.1515/labmed-2019-0005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
15 |
. 白细胞介素-10基因多态性与儿童肠道病毒71型感染的相关性研究. Zhongguo Dang Dai Er Ke Za Zhi 2019;21. [PMID: 31416504 DOI: 10.7499/j.issn.1008-8830.2019.08.010] [Reference Citation Analysis]
|
16 |
. 鼠IL-10基因腺病毒载体的构建及在骨髓间充质干细胞中的表达. Zhongguo Dang Dai Er Ke Za Zhi 2019;21. [PMID: 31315773 DOI: 10.7499/j.issn.1008-8830.2019.07.017] [Reference Citation Analysis]
|
17 |
Meng D, Liang L, Guo X. Serum interleukin-10 level in patients with inflammatory bowel disease: A meta-analysis. Eur J Inflamm 2019;17:205873921984340. [DOI: 10.1177/2058739219843405] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
18 |
Duarte-Silva M, Afonso PC, de Souza PR, Peghini BC, Rodrigues-Júnior V, de Barros Cardoso CR. Reappraisal of antibodies against Saccharomyces cerevisiae (ASCA) as persistent biomarkers in quiescent Crohn's disease. Autoimmunity 2019;52:37-47. [PMID: 30884988 DOI: 10.1080/08916934.2019.1588889] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
19 |
Lin Z, Thorenoor N, Wu R, DiAngelo SL, Ye M, Thomas NJ, Liao X, Lin TR, Warren S, Floros J. Genetic Association of Pulmonary Surfactant Protein Genes, SFTPA1, SFTPA2, SFTPB, SFTPC, and SFTPD With Cystic Fibrosis. Front Immunol 2018;9:2256. [PMID: 30333828 DOI: 10.3389/fimmu.2018.02256] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
|